Navigation Links
Medicaid Data Analysis

An analysis of Medicaid data released today from five states indicates that psychiatric and substance abuse services may be missing their mark if they are limited to community settings, such as community clinics and therapists offices.

Although most intervention policies for co-occurring substance abuse and mental disorders are community-based, a significant number of people with co-occurring disorders never appear in these settings, said study co-author Robin E. Clark, Director of Research, Center for Health Policy and Research, University of Massachusetts Medical School. Substance abuse actually lowers the odds of being treated in a community setting.

The study, funded by the Robert Wood Johnson Foundations Substance Abuse Policy Research Program (SAPRP), shows that when Medicaid beneficiaries have co-occurring disorders, their odds of inpatient and emergency department use and hospital-based psychiatric treatment go up and use of community services goes down, as compared to beneficiaries with just one disorder.

This pattern was clear both for persons with severe and less severe mental disorders. The study was published in the July 2007 issue of Psychiatric Services.

This is occurring despite the fact that primary care studies indicate that continuity of treatment is weaker and costs are higher in hospital settings and data suggest that people treated in these settings have higher rates of inpatient treatment, the authors say.

We need to provide treatment to people wherever they appear in the treatment system instead of increasing treatment in one settingsuch as the community-based settingand hoping they come there, said Clark.

Psychiatric disorders and substance abuse are major problems for the Medicaid population. Diagnosed psychiatric and substance use disorders are from fifty percent to one hundred percent more prevalent among Medicaid beneficiaries than in the general popula tion. Medicaid funds half of state and local support of mental illness treatments and one-third of specialty substance abuse treatment.

The authors set out to understand where integrated psychiatric and substance abuse services may need to be provided for Medicaid beneficiaries. They examined the location of services used by persons with mental and substance use disorders from 1999 Medicaid data obtained from the Centers for Medicare and Medicaid Services for five states: Arkansas, Colorado, Indiana, New Jersey, and Washington.

Robin E. Clark, Ph.D., and Mihail Samnaliev, Ph.D., at the Center for Health Policy and Research, University of Massachusetts Medical School, and Mark P. McGovern, Ph.D., Psychiatric Research Center, Dartmouth Medical School, analyzed whether beneficiaries with co-occurring disorders were treated in community-based settings, inpatient facilities, emergency departments, or hospital outpatient departments.

The full dataset of close to 126,513 beneficiaries ages 21 through 64 included 17,952 Medicaid beneficiaries with co-occurring disorders. Three-fourths of patients with co-occurring disorders were younger than age 45. Racial and ethnic minorities made up a substantial proportion of the population, ranging from 20.8% in Indiana to 61.2% in New Jersey.

Heavy inpatient and emergency department use were common among Medicaid beneficiaries with co-occurring disorders. One in five beneficiaries treated in these settings received no Medicaid funded behavioral health treatment elsewhere. Beneficiaries with co-occurring disorders were three to six times more likely to be hospitalized for psychiatric treatment during 1999 than were those with a mental health diagnosis alone.

Arkansas was the one state in which co-occurring disorders did not reduce the odds that patients would receive community-based mental health treatment. The authors suggest that reimbursement policies favoring com munity mental health centers may increase the likelihood of receiving community treatment.

Calling for a no wrong door approach for Medicaid populations, the authors conclude that attempts to improve mental health and substance abuse treatment for Medicaid beneficiaries with co-occurring disorders should be broad based, focusing on hospital inpatient, emergency department, and outpatient services as well as on community based providers.

In fact, Promising brief interventions for co-occurring disorders designed especially for emergency departments and trauma centers are currently available, says Clark.


'"/>




Related medicine news :

1. Medicaid cuts leave patients in a lurch
2. Homecare Association Highlights Cost-Effectiveness of Medicare and Medicaid
3. Misplaced Priorities in Medicaid Dispensation
4. Bush Administration to Exempt Medicaid Recipients on Proof of Citizenship
5. Few Medicaid Kids with Asthma Get Recommended Flu Shot
6. Medicaid Security Riddled with Flaws
7. Lowest Spending growth in US Medicaid
8. New Medicaid Rule For New Borns
9. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
10. Meta Analysis Links Diabetes And Colorectal Cancer
11. NASA Analysis Say 2005 Was The Warmest Year
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: